Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combined use of an antigestagen and a progesterone synthesis inhibitor of the trilostane and epostane type

Combined use of an antigestagen and a progesterone synthesis inhibitor of the trilostane and epostane type

US Patent 5795881 · Granted Aug 18, 1998

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pro-drug forming compounds2019
Combination of estrogens plus antiprogestins with significant partial agonistic 2017
Pro-drug forming compounds2017
Imidazolyl progesterone antagonists2015
Mesoprogestins (progesterone receptor modulators) for the treatment and preventi2012
2-substituted D-homo-estra-1,3,5(10)-trienes as inhibitors of 17β-hydroxy steroi2010
Antiprogestin method for reducing side effects associated with low dosage HRT an2010
Mesoprogrestins (progesterone receptor modulations) as a component of compositio2009
Progesterone receptor modulators with increased antigonadotropic activity for fe2009
Estradiol prodrugs2009
Compounds with sulphonamide group and pharmaceutical compositions containing the2009
2-substituted D-homo-estra-1,3,5(10)-trienes as inhibitors of 17β-hydroxy steroi2008